Patents Examined by Christopher R. Tate
  • Patent number: 10434129
    Abstract: A method of producing a product to correct hypercholesterolemia including pulping fruits of Emblica officinalis with demineralized water to create a slurry. The slurry is treated with pectinase. The pectinase-treated slurry is filtered to create a solution. The solution is concentrated to create a product. A product having an extract of Emblica officinalis for prophylactic and for therapeutic treatment of coronary diseases, atherosclerosis, hypothyroidism and hyperthyroidism.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: October 8, 2019
    Assignee: ARJUNA NATURAL LTD.
    Inventor: Benny Antony
  • Patent number: 10369179
    Abstract: The invention relates to a herbal composition derived from Mangifera indica. Methods of making and using the composition for the management of obesity are also contemplated.
    Type: Grant
    Filed: September 13, 2015
    Date of Patent: August 6, 2019
    Assignee: Vidya Herbs, Inc.
    Inventor: Kodimule Shyam Prasad
  • Patent number: 10350296
    Abstract: Chewable gelatin formulations that include a bovine gelatin and a fish gelatin.
    Type: Grant
    Filed: July 22, 2014
    Date of Patent: July 16, 2019
    Assignee: Aspire Pharmaceuticals
    Inventors: Madhav Pai, Ritesh Patel
  • Patent number: 10350156
    Abstract: Disclosed are a fermented ginseng berry Pleurotus ferulae product and a cosmetic composition containing the same. The fermented ginseng berry Pleurotus ferulae product is useful for anti-oxidation, anti-inflammation, collagen synthesis facilitation, skin wrinkle care, whitening, moisturizing, skin barrier improvement and atopy alleviation.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: July 16, 2019
    Assignee: AMI COSMETIC CO., LTD.
    Inventors: Kyung Rok Lee, Il Hong, Do Gyeong Lee, Sung Min Park, Jung No Lee, Nu Rim Lee
  • Patent number: 10350257
    Abstract: The present invention provides a pharmaceutical or health functional food containing, as an active ingredient, a complex extract of Crataegi Fructus and Citri Pericarpium. The complex extract has the effects of reducing body weight and lipids in blood vessels.
    Type: Grant
    Filed: June 21, 2013
    Date of Patent: July 16, 2019
    Assignee: NEUMED
    Inventors: Juyeon Park, Dong Wook Lim, Mikyung Song
  • Patent number: 10342834
    Abstract: The present disclosure is related to a method for improving mitochondria in a cell, comprising step of treating the cell with an extraction of Emblica officinalis, for improving ability of mitochondria to perform oxidative phosphorylation and synthesize adenosine triphosphate. The present disclosure is also related to a method for promoting proliferation of a stem cell, comprising step of treating the stem cell with an extraction of Emblica officinalis, for improving division rate of the stem cell.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: July 9, 2019
    Assignee: TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
    Inventors: Han-Chung Cheng, Chi-Tang Tu, Szu-Ting Liu
  • Patent number: 10334869
    Abstract: Methods for increasing the levels of avenanthramides in oats through false malting is disclosed. Oats are first subject to induction or enhancement of a secondary dormancy, and then malted for up to 5 days at an elevated temperature. The malted but not germinated oats are then dried and used as is, or further processed or milled to produce food, feed, nutraceutical or personal care products and ingredients. Methods are also provided for rendering non-dormant oats dormant and thus suitable for false malting.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: July 2, 2019
    Assignee: HER MAJESTY THE QUEEN IN RIGHT OF CANADA, AS REPRESENTED BY THE MINISTER OF AGRICULTURE AND AGRI-FOOD
    Inventors: Frank William Collins, Vernon Douglas Burrows
  • Patent number: 10335356
    Abstract: The present invention discloses a use of neohesperidin or a neohesperidin-containing plant extract in the manufacture of a product for improving and/or promoting skin microcirculation, or for eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation. The present invention also discloses a composition comprising an effective amount of neohesperidin or a neohesperidin-containing plant extract, and to a method for improving and/or promoting skin microcirculation, or eliminating and/or alleviating diseases or conditions associated with poor skin microcirculation, by using neohesperidin. The skin microcirculation of the present invention is preferably eye skin microcirculation.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: July 2, 2019
    Assignee: Natural Medicine Institute of Zhejiang Yangshengtang Co., Ltd.
    Inventors: Liu Hu, Hongying Lan
  • Patent number: 10335383
    Abstract: Exemplary embodiments provide oat fractions, and methods of producing the oat fractions, of the species Avena Sativa that has a concentration of total Avenanthramides that is from about 2 to about 25 wt. %, and up to about 30 wt. % or more, higher than the concentration before treatment with infrared energy. The higher concentration is achieved without treatment with enzymes or exposure to fungal agents to increase the concentration of total Avenanthramides. Instead, the enhanced concentration of Avenanthramides is achieved through exposure to infrared energy for a selected period of time.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: July 2, 2019
    Assignee: The Quaker Oats Company
    Inventors: YiFang Chu, Jodee Johnson, Marianne O'Shea
  • Patent number: 10328018
    Abstract: The present invention relates to the cosmetic use of the essential oil of Laserpitium siler L., as an active agent for preventing and/or treating the signs of aging or photoaging of the skin and as an antioxidant. It also targets a method for cosmetic treatment of the skin in order to combat the signs of skin aging or photoaging and/or to prevent and/or treat skin disorders induced by an oxidative stress and also a composition comprising an essential oil of Laserpitium siler L.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: June 25, 2019
    Assignee: L'OREAL
    Inventors: Agnes Pegeon, Pascale Pelletier, Pierre Lartaud, Corinne Ferraris
  • Patent number: 10328019
    Abstract: Disclosed are topical skin compositions and corresponding methods for their use that include plant extracts. One such composition can include a TNF-? inhibitor, wherein said inhibitor is an aqueous extract from the whole plant of Polygonum multiflorum, an antioxidant and a tyrosinase inhibitor, wherein said antioxidant and tyrosinase inhibitor is an aqueous extract from the whole plant of Lonicera japonica, and a dermatologically acceptable carrier, wherein the composition can include at least 50% by weight of water.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: June 25, 2019
    Assignee: Mary Kay Inc.
    Inventors: Tiffany Florence, David Gan, Michelle Hines
  • Patent number: 10328110
    Abstract: The present invention relates to a composition for promoting osteoblast or cartilage cell differentiation. More particularly, the present invention relates to a composition, which includes stauntonia hexaphylla leaf extract that may be safely used without toxicity and side effects by using a natural ingredient, for promoting bone (tissue) formation to be used for suppressing and treating bone and cartilage tissue damage. A pharmaceutical composition including the stauntonia hexaphylla leaf extract according to the present invention as an active ingredient may be used as a medicine for periodontitis or osteoporosis to treat or prevent periodontitis or osteoporosis.
    Type: Grant
    Filed: April 29, 2014
    Date of Patent: June 25, 2019
    Assignees: JEONNAM BIOINDUSTRY FOUNDATION, YUNGJIN PHARMACEUTICAL CO., LTD.
    Inventors: Chul Yung Choi, Sang O Pan, Hee Jin Seol, Gyu Ok Lee, Wook Jin Jang, Hee Sook Kim, Jae Yong Kim, HuWon Kang, Dong Wook Lee, Sun Oh Kim, Jae Gap Kim, JoonYung Park
  • Patent number: 10322154
    Abstract: Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium infections.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: June 18, 2019
    Assignee: SANTALIS PHARMACEUTICALS, INC.
    Inventors: Ian Clements, Paul Castella, Corey Levenson
  • Patent number: 10314873
    Abstract: A method for treating a disease comprising administering to a mammal in need thereof an effective dosage of an extract of a plant of the genus Hoodia, wherein the disease is selected from the group consisting of immune-mediated disorders, immune-associated disorders, inflammatory diseases, coronary disease, insulin resistance and liver-related diseases. In a preferred embodiment, the Hoodia is Hoodia parviflora. Also disclosed is a pharmaceutical composition for treating the above diseases comprising an effective dosage of an extract of a plant of the genus Hoodia.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: June 11, 2019
    Assignees: HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LIMITED, DESERT LABS AGRICULTURE COOPERATIVE ASSOCIATION LTD.
    Inventors: Refael Aharon, Yaron Ilan
  • Patent number: 10314875
    Abstract: Disclosed herein are methods for treating mammals with HIV/AIDS comprising administering a therapeutically effective amount of a composition comprising an extract of Rubia cordifolia. The extract is preferably an alcohol extract, an aqueous extract, or mixtures thereof. The alcohol preferably comprises ethanol, isopropyl alcohol, or mixtures thereof.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: June 11, 2019
    Assignee: The Florida International University Board of Trustees
    Inventors: Madhavan P. N. Nair, Zainulabedin M. Saiyed, Nimisha H. Gandhi
  • Patent number: 10314874
    Abstract: The present disclosure is drawn to methods for producing natural extracts utilizing fulvic acid solutions as well as the extracts produced utilizing the disclosed methods. The method provides for selecting natural material(s) for extraction and contacting the natural material with a fulvic acid solution. In some embodiments the contacting can occur by pouring, dripping, sprinkling, submersing, or substantially submersing the natural material with the fulvic acid solution.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: June 11, 2019
    Inventors: Christopher Vandecar, Dana Vandecar
  • Patent number: 10307397
    Abstract: Films (ODFs) that include botanical extract are provided, as well as methods of making and using the same.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: June 4, 2019
    Assignee: CONCEPT MATRIX SOLUTIONS
    Inventors: Eric Allen, Robert Davidson, Tony LaRosa, David Reid
  • Patent number: 10300092
    Abstract: The present invention relates to purified compositions of bee bloom, methods of preparing the purified compositions of bee bloom and the use of bee bloom in the reducing and treatment of inflammation.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: May 28, 2019
    Assignee: KANE, Penny Coleen
    Inventors: Penny Colleen Kane, Ronald Duncan Mathison
  • Patent number: 10300101
    Abstract: Embodiments of the invention generally relate to methods and supplements for increasing, enhancing, or maintaining fertility in a human being.
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: May 28, 2019
    Assignee: Quality IP Holdings, LLC
    Inventors: Amy L. Heaton, Mitchell K. Friedlander, Dennis Gay
  • Patent number: 10301396
    Abstract: The present invention relates to process for reducing the endotoxin content of a sample of fermentation broth containing polysialic acid and endotoxin comprising the sequential steps: (i) adding to the sample a base having a pKa of at least 12 to form a basic solution having a pH of at least 12, incubating the solution for a pre-determined time at a pre-determined temperature; and (ii) recovery of PSA, suitably by (iii) passing the sample through an anion-exchange column whereby polysialic acid is absorbed on the ion exchange resin; (iv) washing the column with one washing buffer, whereby polysialic acid remains absorbed on the ion exchange resin; and (v) eluting the polysialic acid from the column using an elution buffer to provide a product solution of polysialic acid having reduced endotoxin content.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: May 28, 2019
    Assignee: Lipoxen Technologies Limited
    Inventors: Sanjay Jain, Peter Laing, Gregory Gregoriadis